Abstract:Maternal immune activation (MIA) caused by exposure to pathogens or inflammation during critical periods of neurodevelopment is a major risk factor for behavioral deficits and psychiatric illness in offspring. A spectrum of behavioral abnormalities can be recapitulated in rodents by inducing MIA using the viral mimetic, PolyI:C. Many studies have focused on long-term changes in brain structure and behavioral outcomes in offspring following maternal PolyI:C exposure, but acute changes in prenatal development ar… Show more
“…Several candidate mechanisms have been proposed in models of MIA which may apply to maternal SARS-CoV-2 infection as well (Figure 1). particularly in the setting of activation via Toll-like receptor (TLR) 7/8 signaling pathways, and to a lesser extent for immune activation via TLR3/TLR4 signaling pathways [42,[88][89][90][91]. (ii) Dysregulated placental serotonin signaling, as the placenta is the primary source of serotonin for the developing fetal brain [92,93].…”
Section: Trends In Molecular Medicinementioning
confidence: 99%
“…(iii) Maternal and placental immune activation are also associated with other alterations in fetal brain neurotransmitter signaling, including the dopaminergic, cholinergic, GABAergic, glutamatergic, and melanocortinergic systems (the latter mediated primarily by dysregulated leptin signaling) that influence fetal brain development and future risk for conditions such as schizophrenia, addiction, and disordered eating [49,[98][99][100][101][102][103]. (iv) Maternal and placental immune activation are associated with placental and fetal brain mitochondrial dysfunction, oxidative stress, and disrupted protein homeostasis [88,91,104,105].…”
The impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection during pregnancy on the developing fetal brain is poorly understood. Other antenatal infections such as influenza have been associated with adverse neurodevelopmental outcomes in offspring. Although vertical transmission has been rarely observed in SARS-CoV-2 to date, given the potential for profound maternal immune activation, impact on the developing fetal brain is likely. Here we review evidence that SARS-CoV-2 and other viral infections during pregnancy can result in maternal, placental and fetal immune activation, and ultimately in offspring neurodevelopmental morbidity. Finally, we highlight the need for cellular models of fetal brain development to better understand potential short- and long-term impacts of maternal SARS-CoV-2 infection on the next generation.
“…Several candidate mechanisms have been proposed in models of MIA which may apply to maternal SARS-CoV-2 infection as well (Figure 1). particularly in the setting of activation via Toll-like receptor (TLR) 7/8 signaling pathways, and to a lesser extent for immune activation via TLR3/TLR4 signaling pathways [42,[88][89][90][91]. (ii) Dysregulated placental serotonin signaling, as the placenta is the primary source of serotonin for the developing fetal brain [92,93].…”
Section: Trends In Molecular Medicinementioning
confidence: 99%
“…(iii) Maternal and placental immune activation are also associated with other alterations in fetal brain neurotransmitter signaling, including the dopaminergic, cholinergic, GABAergic, glutamatergic, and melanocortinergic systems (the latter mediated primarily by dysregulated leptin signaling) that influence fetal brain development and future risk for conditions such as schizophrenia, addiction, and disordered eating [49,[98][99][100][101][102][103]. (iv) Maternal and placental immune activation are associated with placental and fetal brain mitochondrial dysfunction, oxidative stress, and disrupted protein homeostasis [88,91,104,105].…”
The impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection during pregnancy on the developing fetal brain is poorly understood. Other antenatal infections such as influenza have been associated with adverse neurodevelopmental outcomes in offspring. Although vertical transmission has been rarely observed in SARS-CoV-2 to date, given the potential for profound maternal immune activation, impact on the developing fetal brain is likely. Here we review evidence that SARS-CoV-2 and other viral infections during pregnancy can result in maternal, placental and fetal immune activation, and ultimately in offspring neurodevelopmental morbidity. Finally, we highlight the need for cellular models of fetal brain development to better understand potential short- and long-term impacts of maternal SARS-CoV-2 infection on the next generation.
“…These 513 predicted miRNA–mRNA interactions were highly enriched in nervous system development functions and the 85 mRNAs common in the significantly activated nervous system development functions ( Table 1 ) and their predicted interactions with DE miRNAs shown in Figure 4 identified several regulatory networks. The upregulated miR-10a-5p miRNA family was the second most abundant in our NSCs after miR-92a-3p and was predicted to regulate the expression of genes, PRKCI whose down-regulation promotes NOTCH signaling and NSC self-renewal [ 36 ], pro-neural genes RORB, BDNF and RNF112 [ 37 , 38 , 39 ], and HCN1 associated with differentiation of sympathetic neurons [ 40 ]. miR-10a-5p along with miR-30c-5p and miR342-3p, was also predicted to down-regulate the pro-apoptotic gene CASP3 .…”
miRNA regulates the expression of protein coding genes and plays a regulatory role in human development and disease. The human iPSCs and their differentiated progenies provide a unique opportunity to identify these miRNA-mediated regulatory mechanisms. To identify miRNA–mRNA regulatory interactions in human nervous system development, well characterized NSCs were differentiated from six validated iPSC lines and analyzed for differentially expressed (DE) miRNome and transcriptome by RNA sequencing. Following the criteria, moderated t statistics, FDR-corrected p-value ≤ 0.05 and fold change—absolute (FC-abs) ≥2.0, 51 miRNAs and 4033 mRNAs were found to be significantly DE between iPSCs and NSCs. The miRNA target prediction analysis identified 513 interactions between 30 miRNA families (mapped to 51 DE miRNAs) and 456 DE mRNAs that were paradoxically oppositely expressed. These 513 interactions were highly enriched in nervous system development functions (154 mRNAs; FDR-adjusted p-value range: 8.06 × 10−15–1.44 × 10−4). Furthermore, we have shown that the upregulated miR-10a-5p, miR-30c-5p, miR23-3p, miR130a-3p and miR-17-5p miRNA families were predicted to down-regulate several genes associated with the differentiation of neurons, neurite outgrowth and synapse formation, suggesting their role in promoting the self-renewal of undifferentiated NSCs. This study also provides a comprehensive characterization of iPSC-generated NSCs as dorsal neuroepithelium, important for their potential use in in vitro modeling of human brain development and disease.
“…In addition to placental inflammation and neonatal viremia, the transfer of pro-inflammatory cytokines across the placenta could lead to fetal brain cortical malformations, and changes in macrophages function that may be even sustained up to adulthood in accordance with the so-called “ Barker hypothesis of the fetal origin of adult disease ” (Barker, 2001 ). Novel preclinical findings indicate that MIA alters fetal brain development, with implications for long-term cognitive function and behavioral phenotype (Baines et al, 2020 ; Easterlin et al, 2020 ).…”
The emergent Coronavirus Disease 2019 (COVID-19) caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) could produce a maternal immune activation (MIA) via the inflammatory response during gestation that may impair fetal neurodevelopment and lead to postnatal and adulthood mental illness and behavioral dysfunctions. However, so far, limited evidence exists regarding long-term physiological, immunological, and neurodevelopmental modifications produced by the SARS-CoV-2 in the human maternal-fetal binomial and, particularly, in the offspring. Relevant findings derived from epidemiological and preclinical models show that a MIA is indeed linked to an increased risk of neurodevelopmental disorders in the offspring. We hypothesize that a gestational infection triggered by SARS-CoV-2 increases the risks leading to neurodevelopmental disorders of the newborn, which can affect childhood and the long-term quality of life. In particular, disruption of either the maternal or the fetal cholinergic anti-inflammatory pathway (CAP) could cause or exacerbate the severity of COVID-19 in the maternal-fetal binomial. From a translational perspective, in this paper, we discuss the possible manifestation of a MIA by SARS-CoV-2 and the subsequent neurodevelopmental disorders considering the role of the fetal-maternal cytokine cross-talk and the CAP. Specifically, we highlight the urgent need of preclinical studies as well as multicenter and international databanks of maternal-fetal psychophysiological data obtained pre-, during, and post-infection by SARS-CoV-2 from pregnant women and their offspring.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.